N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142179 |
| CAS No | NA |
| Mol.F. | C14H14N2O4 |
| Mol.Wt. | 274.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142180 |
| CAS No | NA |
| Mol.F. | C15H16N2O4 |
| Mol.Wt. | 288.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142181 |
| CAS No | NA |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142182 |
| CAS No | NA |
| Mol.F. | C15H20N2O3 |
| Mol.Wt. | 276.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142184 |
| CAS No | NA |
| Mol.F. | C17H14BrClFN5O4 |
| Mol.Wt. | 486.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142183 |
| CAS No | 51715-17-4 |
| Mol.F. | C16H13ClN4O2 |
| Mol.Wt. | 328.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142185 |
| CAS No | NA |
| Mol.F. | C15H9BrClFN4O3 |
| Mol.Wt. | 427.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142186 |
| CAS No | NA |
| Mol.F. | C21H22BrClFN5O4 |
| Mol.Wt. | 542.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142187 |
| CAS No | NA |
| Mol.F. | C17H14Cl2FN5O4 |
| Mol.Wt. | 442.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142188 |
| CAS No | NA |
| Mol.F. | C16H12BrClFN5O4 |
| Mol.Wt. | 472.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142189 |
| CAS No | NA |
| Mol.F. | C17H19N3OS |
| Mol.Wt. | 313.4 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142190 |
| CAS No | NA |
| Mol.F. | C12H8N2OS |
| Mol.Wt. | 228.27g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142191 |
| CAS No | NA |
| Mol.F. | C17H19N3O2S |
| Mol.Wt. | 329.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142192 |
| CAS No | NA |
| Mol.F. | C29H26N4OS2 |
| Mol.Wt. | 510.67 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142193 |
| CAS No | NA |
| Mol.F. | C56H77N17O13 |
| Mol.Wt. | 1196.34 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0142194 |
| CAS No | NA |
| Mol.F. | C10H12N4OS |
| Mol.Wt. | 236.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |